Free Trial

Aclaris Therapeutics (ACRS) Institutional Ownership

Aclaris Therapeutics logo
$3.96 -0.63 (-13.73%)
(As of 11/20/2024 ET)

Institutional Ownership Changes (13F Filings) for Aclaris Therapeutics (NASDAQ:ACRS)

Current
Institutional Ownership
Percentage
98.34%
Number of
Institutional Buyers
(last 12 months)
22
Total
Institutional Inflows
(last 12 months)
$22.00M
Number of
Institutional Sellers
(last 12 months)
16
Total
Institutional Outflows
(last 12 months)
$8.79M
Get ACRS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aclaris Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ACRS Institutional Buying and Selling by Quarter

Aclaris Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024 Geode Capital Management LLC846,446$974K0.0%+9.3%1.185%
11/15/2024 Jane Street Group LLC82,727$95K0.0%-75.3%0.116%
11/15/2024 State Street Corp188,721$217K0.0%-4.0%0.264%
11/15/2024 Jacobs Levy Equity Management Inc.915,509$1.05M0.0%N/A1.282%
11/15/2024 HighTower Advisors LLC305,814$352K0.0%-2.2%0.428%
11/15/2024 Point72 Asia Singapore Pte. Ltd.52,052$60K0.0%-51.8%0.073%
11/14/2024 Stonepine Capital Management LLC2,458,873$2.83M1.8%+27.6%3.442%
11/13/2024 FMR LLC545,972$628K0.0%-20.8%0.764%
11/8/2024 Connor Clark & Lunn Investment Management Ltd.332,406$382K0.0%+187.6%0.466%
11/5/2024 BML Capital Management LLC14,250,000$16.39M9.6%+9.7%19.973%
11/5/2024 GSA Capital Partners LLP255,032$293K0.0%-24.3%0.357%
10/23/2024 Assenagon Asset Management S.A.185,777$214K0.0%N/A0.261%
10/8/2024 Trium Capital LLP1,912,990$2.20M0.6%+1.1%2.684%
9/16/2024 Point72 Asia Singapore Pte. Ltd.107,929$119K0.0%N/A0.151%
8/21/2024 Stonepine Capital Management LLC1,927,446$2.12M1.9%N/A2.705%
8/15/2024 Millennium Management LLC3,336,850$3.67M0.0%+1.9%4.682%
8/15/2024 AQR Capital Management LLC386,177$425K0.0%-36.9%0.542%
8/15/2024 Point72 Asia Singapore Pte. Ltd.107,929$119K0.0%N/A0.151%
8/12/2024 XTX Topco Ltd24,452$27K0.0%-80.1%0.034%
8/9/2024 Renaissance Technologies LLC922,200$1.01M0.0%-44.9%1.294%
8/9/2024 Dimensional Fund Advisors LP76,759$84K0.0%-13.8%0.108%
8/6/2024 Trium Capital LLP1,892,050$2.08M0.3%N/A2.655%
8/6/2024 Acadian Asset Management LLC1,913,449$2.10M0.0%-10.4%2.685%
8/1/2024 Rhumbline Advisers42,005$46K0.0%-56.8%0.059%
7/30/2024 Deuterium Capital Management LLC72,091$79K0.1%-9.9%0.101%
5/16/2024 Bain Capital Life Sciences Investors LLC3,000,000$3.72M0.3%-14.3%4.210%
5/10/2024 Acadian Asset Management LLC2,135,367$2.65M0.0%-9.2%2.996%
5/10/2024 Vanguard Group Inc.4,929,775$6.11M0.0%+4.4%6.918%
5/8/2024 Russell Investments Group Ltd.62,772$78K0.0%+5,265.1%0.088%
5/7/2024 SG Americas Securities LLC32,843$41K0.0%+69.5%0.046%
5/7/2024 Marquette Asset Management LLC83,979$104K0.0%N/A0.118%
5/7/2024 Deuterium Capital Management LLC79,993$99K0.2%N/A0.112%
5/3/2024 GSA Capital Partners LLP679,137$842K0.1%-57.2%0.953%
5/1/2024 BNP Paribas Financial Markets241,101$299K0.0%+10.9%0.338%
5/1/2024 Mirae Asset Global Investments Co. Ltd.31,552$39K0.0%N/A0.044%
4/23/2024 BML Capital Management LLC9,395,934$11.65M7.7%+1,338.7%13.248%
2/15/2024 Octagon Capital Advisors LP100,000$105K0.0%N/A0.141%
2/13/2024 Bain Capital Life Sciences Investors LLC3,500,000$3.68M0.4%+2.9%4.944%
2/7/2024 Monaco Asset Management SAM979,399$1.03M0.3%N/A1.384%
1/30/2024 Zurcher Kantonalbank Zurich Cantonalbank43,784$46K0.0%+115.5%0.062%
Tesla Execs are Freaking Out (Ad)

It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.

1/30/2024 BML Capital Management LLC653,107$686K0.5%N/A0.923%
1/30/2024 Strs Ohio193,000$202K0.0%+256.7%0.273%
1/30/2024 Vontobel Holding Ltd.30,268$32K0.0%+128.8%0.043%
12/18/2023 Vanguard Group Inc.3,363,046$23.04M0.0%+1.0%4.751%
12/6/2023 Citigroup Inc.11,864$81K0.0%-60.6%0.017%
12/1/2023 Wellington Management Group LLP6,979,844$47.81M0.0%-8.6%9.860%
11/14/2023 Blackstone Inc.1,261,425$8.64M0.0%+9,578.7%1.782%
11/14/2023 Schonfeld Strategic Advisors LLC269,746$1.85M0.0%-40.6%0.381%
11/14/2023 Corton Capital Inc.14,916$102K0.1%N/A0.021%
11/14/2023 Trexquant Investment LP127,851$876K0.0%N/A0.181%
11/13/2023 Algert Global LLC45,120$309K0.0%N/A0.064%
11/13/2023 FMR LLC661,300$4.53M0.0%-11.6%0.934%
11/13/2023 Lord Abbett & CO. LLC453,954$3.11M0.0%+14.0%0.641%
11/9/2023 Deutsche Bank AG154,309$1.06M0.0%-85.8%0.218%
11/8/2023 HighTower Advisors LLC369,802$2.53M0.0%-2.6%0.522%
11/7/2023 Barclays PLC234,150$1.60M0.0%+174.2%0.331%
11/6/2023 Assenagon Asset Management S.A.687,135$4.71M0.0%+7.9%0.971%
10/25/2023 Zurcher Kantonalbank Zurich Cantonalbank20,317$139K0.0%+42.6%0.029%
10/13/2023 SG Americas Securities LLC151,704$1.04M0.0%+20.1%0.214%
9/21/2023 Barclays PLC85,389$885K0.0%-54.7%0.121%
8/15/2023 HighVista Strategies LLC86,103$893K0.4%-56.5%0.122%
8/15/2023 Braidwell LP2,901,194$30.09M1.0%-11.3%4.098%
8/11/2023 Westwood Holdings Group Inc.51,023$529K0.0%N/A0.072%
8/11/2023 Hsbc Holdings PLC249,842$2.61M0.0%N/A0.353%
8/7/2023 Principal Financial Group Inc.19,133$198K0.0%+13.0%0.027%
8/4/2023 American International Group Inc.33,429$347K0.0%+7.2%0.047%
8/3/2023 Los Angeles Capital Management LLC75,006$778K0.0%N/A0.106%
8/3/2023 Barclays PLC85,389$885K0.0%-54.7%0.121%
8/3/2023 Bank of New York Mellon Corp242,426$2.51M0.0%+5.3%0.343%
7/31/2023 Strs Ohio54,100$561K0.0%+8.4%0.077%
7/25/2023 Assenagon Asset Management S.A.636,829$6.60M0.0%+49.6%0.901%
7/10/2023 SG Americas Securities LLC126,347$1.31M0.0%+323.4%0.179%
5/16/2023 BVF Inc. IL3,360,941$27.19M1.0%+2.6%4.755%
5/16/2023 Bain Capital Life Sciences Investors LLC3,400,000$27.51M3.4%N/A4.810%
5/15/2023 Commodore Capital LP635,000$5.14M0.8%-66.2%0.898%
5/15/2023 Ghost Tree Capital LLC425,000$3.44M1.0%N/A0.601%
5/12/2023 Wellington Management Group LLP7,372,601$59.64M0.0%+34.4%10.431%
5/10/2023 Connor Clark & Lunn Investment Management Ltd.176,650$1.43M0.0%+948.6%0.250%
5/10/2023 Ovata Capital Management Ltd15,000$121K0.1%N/A0.021%
5/2/2023 Amalgamated Bank9,098$74K0.0%-13.0%0.013%
4/28/2023 SG Americas Securities LLC29,843$241K0.0%+305.4%0.042%
4/27/2023 Strs Ohio49,900$403K0.0%+37.1%0.071%
4/18/2023 Assenagon Asset Management S.A.425,828$3.45M0.0%+118.5%0.639%
4/12/2023 Vontobel Holding Ltd.14,228$115K0.0%N/A0.021%
3/23/2023 MetLife Investment Management LLC33,899$534K0.0%+8.4%0.051%
2/22/2023 Teachers Retirement System of The State of Kentucky57,009$898K0.0%+5.6%0.085%
2/15/2023 Braidwell LP2,393,985$37.71M1.3%N/A3.590%
2/14/2023 Verition Fund Management LLC405,568$6.39M0.1%+8.9%0.608%
2/13/2023 Renaissance Technologies LLC1,121,752$17.67M0.0%-5.4%1.682%
2/10/2023 Connor Clark & Lunn Investment Management Ltd.16,846$265K0.0%-37.3%0.025%
When it comes to NVDA… “acceleration cycles” are the key (Ad)

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!
2/10/2023 HRT Financial LP45,535$717K0.0%N/A0.068%
2/10/2023Cheyne Capital Management UK LLP50,964$803K1.4%N/A0.076%
2/9/2023 Mirae Asset Global Investments Co. Ltd.31,135$490K0.0%+16.6%0.047%
2/9/2023 Aisling Capital Management LP434,455$6.84M4.5%-31.5%0.652%
2/9/2023 Principal Financial Group Inc.18,208$287K0.0%+11.0%0.027%
2/9/2023 HighTower Advisors LLC192,424$3.03M0.0%+229.8%0.289%
2/8/2023 Swiss National Bank112,600$1.77M0.0%+1.9%0.169%
2/7/2023 Fox Run Management L.L.C.16,350$258K0.1%+9.5%0.025%
2/7/2023 Handelsbanken Fonder AB14,800$233K0.0%N/A0.022%
2/3/2023 Frazier Life Sciences Management L.P.290,189$4.57M0.3%-28.9%0.435%
(Data available from 1/1/2016 forward)

ACRS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ACRS shares?

During the previous two years, 68 institutional investors and hedge funds held shares of Aclaris Therapeutics. The most heavily invested institutionals were Wellington Management Group LLP ($47.81M), Braidwell LP ($30.09M), BVF Inc. IL ($27.19M), BML Capital Management LLC ($16.39M), Blackstone Inc. ($8.64M), Aisling Capital Management LP ($6.84M), and Verition Fund Management LLC ($6.39M).Learn more on ACRS's institutional investors.

What percentage of Aclaris Therapeutics stock is owned by institutional investors?

98.34% of Aclaris Therapeutics stock is owned by institutional investors. Learn more on ACRS's institutional investor holdings.

Which institutional investors have been buying Aclaris Therapeutics stock?

Of the 49 institutional investors that purchased Aclaris Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($10.66M), Bain Capital Life Sciences Investors LLC ($3.50M), Stonepine Capital Management LLC ($2.46M), Braidwell LP ($2.39M), Trium Capital LLP ($1.91M), Wellington Management Group LLP ($1.89M), and Blackstone Inc. ($1.25M).

How much institutional buying is happening at Aclaris Therapeutics?

Institutional investors have bought a total of 29,981,459 shares in the last 24 months. This purchase volume represents approximately $134.34M in transactions.

Which Aclaris Therapeutics major shareholders have been selling company stock?

Of the 28 institutional investors that sold Aclaris Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Commodore Capital LP ($1.25M), GSA Capital Partners LLP ($990.50K), Deutsche Bank AG ($932.31K), Renaissance Technologies LLC ($814.63K), Wellington Management Group LLP ($658.02K), Bain Capital Life Sciences Investors LLC ($500K), and Acadian Asset Management LLC ($437.96K).

How much institutional selling is happening at Aclaris Therapeutics?

Institutional investors have sold a total of 7,767,557 shares in the last 24 months. This volume of shares sold represents approximately $40.58M in transactions.



This page (NASDAQ:ACRS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners